54 medicines held by Bristol-Myers Squibb Pharma EEIG on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Vidaza 25 mg/mL powder for suspension for injection EU/1/08/488/001 |
Azacitidine | Bristol-Myers Squibb Pharma EEIG | — |
| YERVOY 5 mg/ml concentrate for solution for infusion EU/1/11/698/001-002 |
Ipilimumab | Bristol-Myers Squibb Pharma EEIG | — |
| Zeposia 0.23 mg hard capsules Zeposia 0.46 mg hard capsules EU/1/20/1442/001 |
OZANIMOD | Bristol-Myers Squibb Pharma EEIG | — |
| Zeposia 0.92 mg hard capsules EU/1/20/1442/002-003 |
OZANIMOD | Bristol-Myers Squibb Pharma EEIG | — |
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.